Small molecule myristate inhibitors of Bcr-abl and methods of use
US9670214B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 13, 2014 |
| Grant date | Jun 6, 2017 |
| Priority date | — |
| Expiry date | Nov 13, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel heteroaryl compounds of formula (I) having a pyrimidine-containing core that is linked to a 4-trifluoromethoxyphenyl group via an amine linker. Such compounds are useful for the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.